Investors Bag RVNC 46.7% Cheaper Than Its Secondary Stock Offering
February 04, 2016 at 11:32 AM EST
Looking back to 92 days ago, Revance Therapeutics Inc (RVNC) priced a 3,250,000 share secondary stock offering at $36.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..